398120 — SG HealthCare Co Income Statement
0.000.00%
Last trade - 00:00- KR₩31bn
- KR₩36bn
- KR₩16bn
Annual income statement for SG HealthCare Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 25,499 | 27,779 | 16,105 |
| Cost of Revenue | |||
| Gross Profit | 6,189 | 7,111 | 5,158 |
| Selling / General / Administrative Expenses | |||
| Research And Development | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Total Operating Expenses | 23,740 | 25,616 | 16,790 |
| Operating Profit | 1,759 | 2,163 | -686 |
| Gain / Loss on Sale of Assets | |||
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | -268 | 2,115 | -3,655 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -451 | 1,776 | -3,533 |
| Minority Interest | |||
| Net Income Before Extraordinary Items | |||
| Net Income | -451 | 1,767 | -3,547 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -451 | 1,767 | -3,547 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -41.3 | 168 | -380 |
| Dividends per Share |